Gene therapy for lung diseases: development in the vector biology and novel concepts for gene therapy applications

Current Molecular Medicine
M SuzukiY Isigatsubo

Abstract

The lung represents an attractive target organ for somatic gene therapy strategy in that, (1) it is easily accessible by vectors, (2) most frequent hereditary disorders, cystic fibrosis (CF) and alpha1-antitrypsin deficiency (alpha1AT), occur in the lung, and (3) carcinoma of the lung is apparently a most common cause of death in humans. To date, approximately 400 clinical protocols for human gene therapy have been approved, and approximately 10% of the protocols target lung diseases such as cystic fibrosis (CF) and lung cancer. Currently available data from some of these human trials have successfully demonstrated that gene transfer to the human lung is possible, and that the strategy of overexpressing exogenous genes for curing or controlling lung diseases is potentially promising. In this manuscript, focusing on gene therapy of lung disorders, we aim to give an overview of the hurdles of current gene transfer strategies to overcome, then and also we aim to review recent, remarkable progresses in the vector biology that are potentially promising to maximize safety and efficiency of gene therapy. In addition, based on the most recent advances in the understanding of the molecular biological aspects of the pathogenesis of lung ...Continue Reading

Citations

Oct 23, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rejean Liqun WangTerence R Flotte
Feb 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Vladimir P TorchilinGerard G M D'Souza
Apr 26, 2013·Inhalation Toxicology·Jie ShenGuoxiong Xu
Jul 21, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Indrajit Roy, Neeraj Vij
Apr 1, 2006·Diseases of the Colon and Rectum·Fabiana Pirani CarneiroSérgio Zucoloto
Apr 8, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Ziyao KangKeliang Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.